Meeting
2014 ASCO Annual Meeting
An estimation model for Oncotype DX recurrence score using routine histopathologic variables.
Authors
Hyunseok Kim
The Johns Hopkins University School of Medicine, Baltimore, MD
Hyunseok Kim , Christopher Umbricht , Peter B. Illei , Maria Cristina Figueroa Magalhaes , Catherine Pesce , Michele Maiko Gage , Charles Mylander , Martin Rosman , Lorraine Tafra , Kala Visvanathan , Leslie Cope , Antonio C. Wolff
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 559)
DOI
10.1200/jco.2014.32.15_suppl.559
Abstract #
559
Poster Bd #
23
Abstract Disclosures
Similar Posters
Poster
2012 Breast Cancer Symposium
Comparison of immunohistochemistry (IHC) and quantitative RT-PCR: ER, PR, and HER2 receptor status.
First Author: Cindy Christopherson
Poster
2012 Breast Cancer Symposium
Estrogen receptor-positive, progesterone receptor-negative tumors: Pathology and outcome correlations from a single-center cohort.
First Author: Oana Danciu
Poster
2023 ASCO Annual Meeting
Correlation between Oncotype DX, Predict, and Nottingham Prognostic Index on HR+, HER2- early breast cancer treatment: The current value of molecular testing.
First Author: Leticia Campoverde
Poster
2021 ASCO Annual Meeting
Breast cancer ER, PR, and HER2 expression variance by germline cancer predisposition genes.
First Author: Grace Wei